Dr. Kelly, a renowned medical oncologist, is an active, long-standing member of the IASLC and a former member of the IASLC Board of Directors. She is recognized internationally for her expertise in lung cancer research and her career has been dedicated to providing enhanced cancer care through cutting-edge clinical trials. Dr. Kelly’s lung cancer research has involved all aspects of the disease from risk reduction and screening to treatment. She has been at the forefront of drug development to treat lung cancer throughout her career. Dr. Kelly most recently has served as Professor of Medicine and Associate Director for Clinical Research, University of California, Davis Comprehensive Cancer Center and held the Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon Endowed Chair in Cancer Clinical Research at UC Davis. She frequently lectures on lung cancer topics, nationally and internationally. Dr. Kelly has authored or co-authored more than 190 publications, including original papers, reviews, and book chapters.  She has served as the chair of the Lung Committee for SWOG, one of the nation’s leading cooperative cancer research organizations, since 2016.